The public PhD defence of Philippe GIRON entitled “Exploiting genomic vulnerabilities in lung cancer for therapeutic targeting” will take place on Tuesday, 3 May 2022 at 5 p.m. in Auditorium...
Author: Isabelle Houbracken
https://leadwire.com/stream/IsXbxn
Cancer patients who have survived serious treatment and are free of the disease often suffer an enormous psychological blow afterwards and find it difficult to pick up the thread of...
BOOST programme aims to help care providers listen “The goal is to improve communication between young cancer patients (between 10 and 18 years old), their parents and the medical staff,...
The teams of VUB professors Bart Neyns, Sandra Tuyaerts and Karine Breckpot will join research groups from UCL, Bordet Institute and ULB in their search for factors that explain why...
Two research groups from the Vrije Universiteit Brussel have established a collaboration in which they predict the response to the standard treatment for rectal cancer based on medical images (e.g....
Researchers at the Vrije Universiteit Brussel, led by Prof Dr Eline Menu, have investigated how changes in metabolism contribute to cancer resistance and relapse. They identified the amino acid proline...
In-patient cell engineering to upgrade immune cells’ capacity to identify and destroy cancer cells is the challenge taken on by the Walloon startup Esobiotec, founded by Jean-Pierre Latere, and two...
The public PhD defence of Elyne BACKX entitled “The Neoplastic Potential of Pancreatic Cell Populations” will take place on Tuesday, 26 October 2021 at 5 p.m. in Auditorium Piet Brouwer...
The public PhD defence of Rose MIRANDA entitled “Palliative care for older people with dementia in nursing homes and at home: multi-country descriptive and interventional research” will take place on...